211 related articles for article (PubMed ID: 12018569)
1. Cure in a case of primary hepatic lymphoma.
Murthy SA; Singh B; Bhalla S; Arora A; Vohra R; Aggarwal S
Indian J Cancer; 2000 Dec; 37(4):165-72. PubMed ID: 12018569
[TBL] [Abstract][Full Text] [Related]
2. [Malignant lymphoma].
Hirano M
Nihon Naika Gakkai Zasshi; 1994 Mar; 83(3):363-7. PubMed ID: 7525807
[No Abstract] [Full Text] [Related]
3. Primary colorectal T-cell lymphoma.
Okada M; Maeda K; Suzumiya J; Hagimoto T; Wakamatsu S; Ohshima K; Kanda M; Sonoda T; Sakamoto A; Tamura K
J Gastroenterol; 2003; 38(4):376-84. PubMed ID: 12743779
[TBL] [Abstract][Full Text] [Related]
4. Treatment of relapsed aggressive lymphomas: regimens with and without high-dose therapy and stem cell rescue.
Hagemeister FB
Cancer Chemother Pharmacol; 2002 May; 49 Suppl 1():S13-20. PubMed ID: 12042984
[TBL] [Abstract][Full Text] [Related]
5. An international evaluation of CODOX-M and CODOX-M alternating with IVAC in adult Burkitt's lymphoma: results of United Kingdom Lymphoma Group LY06 study.
Mead GM; Sydes MR; Walewski J; Grigg A; Hatton CS; Pescosta N; Guarnaccia C; Lewis MS; McKendrick J; Stenning SP; Wright D;
Ann Oncol; 2002 Aug; 13(8):1264-74. PubMed ID: 12181251
[TBL] [Abstract][Full Text] [Related]
6. Randomized open label phase III trial of CEOP/IMVP-Dexa alternating chemotherapy and filgrastim versus CEOP/IMVP-Dexa alternating chemotherapy for aggressive non-Hodgkin's lymphoma (NHL). A multicenter trial by the Austrian Working Group for Medical Tumor Therapy.
Fridrik MA; Greil R; Hausmaninger H; Krieger O; Oppitz P; Stöger M; Klocker J; Neubauer M; Helm W; Pont J; Fazeny B; Hudec M; Simonitsch I; Radaszkiewicz T
Ann Hematol; 1997 Oct; 75(4):135-40. PubMed ID: 9402845
[TBL] [Abstract][Full Text] [Related]
7. Multiple cutaneous relapses in an adolescent in anaplastic large cell lymphoma diagnosed by FNAC.
Mandal S; Varma K; Jain S
Cytopathology; 2008 Apr; 19(2):127-9. PubMed ID: 18070116
[No Abstract] [Full Text] [Related]
8. [Primary lymphoma of the thyroid with contralateral recurrence--case report].
Pichler R; Hatzl-Griesenhofer M; Huber H; Wimmer G; Wahl G; Maschek W
Wien Klin Wochenschr; 1999 Apr; 111(8):329-32. PubMed ID: 10378315
[TBL] [Abstract][Full Text] [Related]
9. Chemotherapy in patients with acquired immunodeficiency virus syndrome associated with non-Hodgkin's lymphoma.
Fridrik MA; Geit M; Wahl G; Ehrengruber A; Simma R; Höpfel I; Bettelheim P; Leisch F
Wien Klin Wochenschr; 1998 Jan; 110(1):15-9. PubMed ID: 9499473
[TBL] [Abstract][Full Text] [Related]
10. Association of intestinal malignant lymphoma and ulcerative colitis.
Watanabe N; Sugimoto N; Matsushita A; Maeda A; Nagai K; Hanioka K; Takahashi T
Intern Med; 2003 Dec; 42(12):1183-7. PubMed ID: 14714955
[TBL] [Abstract][Full Text] [Related]
11. [Treatment of lymphoma in the aged].
Gómez H; Colomer R
Med Clin (Barc); 1998 May; 110(15):574-5. PubMed ID: 9650201
[No Abstract] [Full Text] [Related]
12. Treatment of Burkitt's lymphoma during pregnancy.
Lam MS
Ann Pharmacother; 2006 Nov; 40(11):2048-52. PubMed ID: 17062832
[TBL] [Abstract][Full Text] [Related]
13. Combination chemotherapy followed by an immunotoxin (anti-B4-blocked ricin) in patients with indolent lymphoma: results of a phase II study.
Longo DL; Duffey PL; Gribben JG; Jaffe ES; Curti BD; Gause BL; Janik JE; Braman VM; Esseltine D; Wilson WH; Kaufman D; Wittes RE; Nadler LM; Urba WJ
Cancer J; 2000; 6(3):146-50. PubMed ID: 10882329
[TBL] [Abstract][Full Text] [Related]
14. Dose-dense therapy improves survival in aggressive non-Hodgkin's lymphoma.
Fridrik MA; Hausmaninger H; Lang A; Drach J; Krieger O; Geissler D; Michlmayr G; Ulsperger E; Chott A; Oberaigner W; Greil R
Ann Hematol; 2010 Mar; 89(3):273-82. PubMed ID: 19693500
[TBL] [Abstract][Full Text] [Related]
15. Sequential salvage chemotherapy for recurrent intracranial hemangiopericytoma.
Chamberlain MC; Glantz MJ
Neurosurgery; 2008 Oct; 63(4):720-6; author reply 726-7. PubMed ID: 18981882
[TBL] [Abstract][Full Text] [Related]
16. Dose-Adjusted EPOCH-R and Mid-Cycle High Dose Methotrexate for Patients with Systemic Lymphoma and secondary CNS Involvement.
Chihara D; Fowler NH; Oki Y; Fanale MA; Fayad LE; Westin JR; Hagemeister FB
Br J Haematol; 2017 Dec; 179(5):851-854. PubMed ID: 27502933
[No Abstract] [Full Text] [Related]
17. [Primary rhabdomyosarcoma of the temporal bone].
Lorenzo Núñez R; Ramos Benavente MD; Morales Jiménez C; Ruiz Medina E
Acta Otorrinolaringol Esp; 1995; 46(1):53-6. PubMed ID: 7734166
[TBL] [Abstract][Full Text] [Related]
18. Syngeneic transplant in mantle cell lymphoma: a rare event and review of the literature.
Engman CA; Hill JM; Meehan KR
Clin Adv Hematol Oncol; 2009 May; 7(5):321-3. PubMed ID: 19521320
[No Abstract] [Full Text] [Related]
19. When lymphoma and heart failure cross paths.
Nomiyama K; Shibuya T; Kataoka C; Aoki Y
J Hematother Stem Cell Res; 2003 Feb; 12(1):7-8. PubMed ID: 12662430
[No Abstract] [Full Text] [Related]
20. Cutaneous plasmablastic lymphoma.
Jambusaria A; Shafer D; Wu H; Al-Saleem T; Perlis C
J Am Acad Dermatol; 2008 Apr; 58(4):676-8. PubMed ID: 18342714
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]